AAAAAA
Results:
1-11
|
Results: 11
Authors:
Tan, ACITL
Brouwer, JT
Glue, P
van Leusen, R
Kauffmann, RH
Schalm, SW
de Vries, RA
Vroom, B
Citation: Acitl. Tan et al., Safety of interferon and ribavirin therapy in haemodialysis patients with chronic hepatitis C: results of a pilot study, NEPH DIAL T, 16(1), 2001, pp. 193-195
Authors:
Unal, G
de Boer, JB
Borsboom, GJJM
Brouwer, JT
Essink-Bot, ML
de Man, RA
Citation: G. Unal et al., A psychometric comparison of health-related quality of life measures in chronic liver disease, J CLIN EPID, 54(6), 2001, pp. 587-596
Authors:
Bekkering, FC
Stalgis, C
McHutchison, JG
Brouwer, JT
Perelson, AS
Citation: Fc. Bekkering et al., Estimation of early hepatitis C viral clearance in patients receiving daily interferon and ribavirin therapy using a mathematical model, HEPATOLOGY, 33(2), 2001, pp. 419-423
Authors:
Bekkering, FC
Brouwer, JT
Hansen, BE
Schalm, SW
Citation: Fc. Bekkering et al., Hepatitis C viral kinetics in difficult to treat patients receiving high dose interferon and ribavirin, J HEPATOL, 34(3), 2001, pp. 435-440
Authors:
Depraetere, S
Van Kerschaever, E
Vlierberghe, HV
Elewaut, A
Brouwer, JT
Niesters, HGM
Schalm, SW
Maertens, G
Leroux-Roels, G
Citation: S. Depraetere et al., Long term response to interferon treatment in chronic hepatitis C patientsis associated with a significant reduction in anti-E1 envelope antibody titers, J MED VIROL, 60(2), 2000, pp. 126-132
Authors:
Eland, IA
Rasch, MC
Sturkenboom, MJCM
Bekkering, FC
Brouwer, JT
Delwaide, J
Belaiche, J
Houbiers, G
Stricker, BHC
Citation: Ia. Eland et al., Acute pancreatitis attributed to the use of interferon alfa-2b, GASTROENTY, 119(1), 2000, pp. 230-233
Authors:
Van Rossum, TGJ
Vulto, AG
Hop, WCJ
Brouwer, JT
Niesters, HGM
Schalm, SW
Citation: Tgj. Van Rossum et al., Intravenous glycyrrhizin for the treatment of chronic hepatitis C: A double-blind, randomized, placebo-controlled phase I/II trial, J GASTR HEP, 14(11), 1999, pp. 1093-1099
Authors:
Schalm, SW
Brouwer, JT
Bekkering, FC
van Rossum, TGJ
Citation: Sw. Schalm et al., New treatment strategies in non-responder patients with chronic hepatitis C, J HEPATOL, 31, 1999, pp. 184-188
Authors:
Brouwer, JT
Hansen, BE
Niesters, HGM
Schalm, SW
Citation: Jt. Brouwer et al., Early prediction of response in interferon monotherapy and in interferon-ribavirin combination therapy for chronic hepatitis C: HCV RNA at 4 weeks versus ALT, J HEPATOL, 30(2), 1999, pp. 192-198
Authors:
Schalm, SW
Weiland, O
Hansen, BE
Milella, M
Lai, FY
Hollander, A
Michielsen, PP
Bellobuono, A
Chemello, L
Pastore, G
Chen, DS
Brouwer, JT
Citation: Sw. Schalm et al., Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: Analysis of individual patient data of six controlled trials, GASTROENTY, 117(2), 1999, pp. 408-413
Authors:
Schalm, SW
Brouwer, JT
Citation: Sw. Schalm et Jt. Brouwer, Up to date treatment of hepatitis C in adults, ACT GASTR B, 61(4), 1998, pp. 397-399
Risultati:
1-11
|